Skip to content
Sign In Subscribe
Supplier News

Qualitest cleared to market Myzilra tablets

Qualitest Pharmaceuticals has received approval from the Food and Drug Administration for Myzilra tablets, an oral contraceptive. The company said Monday that the FDA approved Myzilra tablets (levonorgestrel and ethinyl estradiol) 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.

,   and  Chain Drug Review
1 min read

Table of Contents

HUNTSVILLE, Ala. — Qualitest Pharmaceuticals has received approval from the Food and Drug Administration for Myzilra tablets, an oral contraceptive.

The company said Monday that the FDA approved Myzilra tablets (levonorgestrel and ethinyl estradiol) 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.03 mg in a 28-day triphasic regimen.

Total sales for Myzilra tablets in the United States for the 12 months ended Sept. 30 were approximately $34.4 million, according to IMS Health data cited by Qualitest.

Comments

Related

Latest

FMI: Private brands take hold
Retail News

FMI: Private brands take hold

Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”

,   and  Chain Drug Review